FDA Approves Veklury® for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression Pharmaceutical Investing
U.S. FDA Approves Second Indication for SKYRIZI® to Treat Adults with Active Psoriatic Arthritis Pharmaceutical Investing
BioHarvest Sciences Inc. Plans to Build a Production Facility in Ontario to Serve the Canadian Market with Unique Cannabis Products Life Science Investing
LUMAKRAS® RECEIVES APPROVAL IN JAPAN FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER Market News
BriaCell Therapeutics Corp. Announces Results of 2022 Annual and Special Meeting of Shareholders Life Science Investing
Cardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory Board Pharmaceutical Investing
Gilead Sciences to Release Fourth Quarter & Full Year 2021 Financial Results on Tuesday, February 1, 2022 Pharmaceutical Investing
Sirona Biochem Renews Agreement with CURE Intelligence for Marketing and Communications Support Life Science Investing
U.S. FDA Approves RINVOQ® to Treat Adults and Children 12 Years and Older with Refractory, Moderate to Severe Atopic Dermatitis Pharmaceutical Investing
Naturally Splendid Closes Second Tranche of $1,120,456 for a Total Raise of $3,270,971 Life Science Investing
